Picture of Axonics logo

AXNX — Axonics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Boston Scientific Corp Expects FY EPS On A GAAP Basis In A Range Of $1.43 To $1.48

April 24 (Reuters) - Axonics Inc  AXNX.O :
    * SEES FY EPS ON A GAAP BASIS IN A RANGE OF $1.43 TO $1.48
    * SEES FY ADJUSTED EPS, EXCLUDING CERTAIN CHARGES (CREDITS),
OF
$2.29 TO $2.34
    * SEES NET SALES GROWTH FOR FY 2024, TO BE IN RANGE OF
APPROXIMATELY 11 TO 13 PERCENT ON A REPORTED BASIS
    * SEES FY  NET SALES GROWTH FOR FULL YEAR 2024, TO BE IN
RANGE OF
10 TO 12 PERCENT ON AN ORGANIC BASIS
    * SEES NET SALES GROWTH FOR Q2 OF 2024, TO BE IN A RANGE OF
ABOUT
10.5 TO 12.5 PERCENT ON A REPORTED BASIS
    * SEES Q2 EPS ON A GAAP BASIS IN A RANGE OF $0.35 TO $0.37
AND
ADJUSTED EPS, OF $0.57 TO $0.59


 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Axonics

See all news